Integrated Care Increases Treatment and Improves Outcomes of Patients With Chronic Hepatitis C Virus Infection and Psychiatric Illness or Substance Abuse
- PMID: 25724704
- DOI: 10.1016/j.cgh.2015.02.022
Integrated Care Increases Treatment and Improves Outcomes of Patients With Chronic Hepatitis C Virus Infection and Psychiatric Illness or Substance Abuse
Abstract
Background & aims: Patients with hepatitis C virus (HCV) infection with psychiatric disorders and/or substance abuse face significant barriers to antiviral treatment. New strategies are needed to improve treatment rates and outcomes. We investigated whether an integrated care (IC) protocol, which includes multidisciplinary care coordination and patient case management, could increase the proportion of patients with chronic HCV infection who receive antiviral treatment (a combination of interferon-based and direct-acting antiviral agents) and achieve a sustained virologic response (SVR).
Methods: We performed a prospective randomized trial at 3 medical centers in the United States. Participants (n = 363 patients attending HCV clinics) had been screened and tested positive for depression, post-traumatic stress disorder, and/or substance use; they were assigned randomly to groups that received IC or usual care (controls) from March 2009 through February 2011. A midlevel mental health practitioner was placed at each HCV clinic to provide IC with brief mental health interventions and case management, according to formal protocol. The primary end point was SVR.
Results: Of the study participants, 63% were non-white, 51% were homeless in the past 5 years, 64% had psychiatric illness, 65% were substance abusers within 1 year before enrollment, 57% were at risk for post-traumatic stress disorder, 71% had active depression, 80% were infected with HCV genotype 1, and 23% had advanced fibrosis. Over a mean follow-up period of 28 months, a greater proportion of patients in the IC group began receiving antiviral therapy (31.9% vs 18.8% for controls; P = .005) and achieved a SVR (15.9% vs 7.7% of controls; odds ratio, 2.26; 95% confidence interval, 1.15-4.44; P = .018). There were no differences in serious adverse events between groups.
Conclusions: Integrated care increases the proportion of patients with HCV infection and psychiatric illness and/or substance abuse who begin antiviral therapy and achieve SVRs, without serious adverse events. ClinicalTrials.gov # NCT00722423.
Keywords: Care Integration; Hepatitis C; PTSD; Substance Use Disorders.
Copyright © 2015 AGA Institute. Published by Elsevier Inc. All rights reserved.
Comment in
-
Expanding the Scope of Integrated Behavioral Health Care for Patients With Hepatitis C Virus.Clin Gastroenterol Hepatol. 2015 Nov;13(11):2015-6. doi: 10.1016/j.cgh.2015.04.174. Epub 2015 May 5. Clin Gastroenterol Hepatol. 2015. PMID: 25952310 No abstract available.
Similar articles
-
Increasing antiviral treatment through integrated hepatitis C care: a randomized multicenter trial.Contemp Clin Trials. 2013 Jul;35(2):97-107. doi: 10.1016/j.cct.2013.05.002. Epub 2013 May 10. Contemp Clin Trials. 2013. PMID: 23669414 Clinical Trial.
-
Spectrum of disease in U.S. veteran patients with hepatitis C.Am J Gastroenterol. 2002 Jul;97(7):1813-20. doi: 10.1111/j.1572-0241.2002.05800.x. Am J Gastroenterol. 2002. PMID: 12135041
-
Hepatitis C treatment for multimorbid patients with substance use disorder in a primary care-based integrated treatment centre: a retrospective analysis.Eur J Gastroenterol Hepatol. 2013 Nov;25(11):1300-7. doi: 10.1097/MEG.0b013e32836140bb. Eur J Gastroenterol Hepatol. 2013. PMID: 23571610
-
Time to rethink antiviral treatment for hepatitis C in patients with coexisting mental health/substance abuse issues.Dig Dis Sci. 2012 Jun;57(6):1469-74. doi: 10.1007/s10620-012-2141-4. Epub 2012 Apr 7. Dig Dis Sci. 2012. PMID: 22484494 Free PMC article. Review.
-
Management of chronic hepatitis C in veterans: the potential of integrated care models.Am J Gastroenterol. 2008 Jul;103(7):1810-23. doi: 10.1111/j.1572-0241.2008.01877.x. Epub 2008 Jun 28. Am J Gastroenterol. 2008. PMID: 18564122 Review.
Cited by
-
Assessment of hepatitis C monitoring adherence after viral eradication in veterans with substance use to improve care and surveil reinfection.Ment Health Clin. 2022 Jun 10;12(3):181-186. doi: 10.9740/mhc.2022.06.181. eCollection 2022 Jun. Ment Health Clin. 2022. PMID: 35801159 Free PMC article.
-
Can Telemedicine Optimize the HCV Care Cascade in People Who Use Drugs? Features of an Innovative Decentralization Model and Comparison with Other Micro-Elimination Strategies.Biology (Basel). 2022 May 24;11(6):805. doi: 10.3390/biology11060805. Biology (Basel). 2022. PMID: 35741326 Free PMC article. Review.
-
Closing the hepatitis C treatment gap: United States strategies to improve retention in care.J Viral Hepat. 2022 Aug;29(8):588-595. doi: 10.1111/jvh.13685. Epub 2022 May 26. J Viral Hepat. 2022. PMID: 35545901 Review.
-
Integrating Management of Hepatitis C Infection into Primary Care: the Key to Hepatitis C Elimination Efforts.J Gen Intern Med. 2022 Apr 28. doi: 10.1007/s11606-022-07628-9. Online ahead of print. J Gen Intern Med. 2022. PMID: 35484367 Review.
-
Interventions to increase linkage to care and adherence to treatment for hepatitis C among people who inject drugs: A systematic review and practical considerations from an expert panel consultation.Int J Drug Policy. 2022 Apr;102:103588. doi: 10.1016/j.drugpo.2022.103588. Epub 2022 Jan 29. Int J Drug Policy. 2022. PMID: 35101667 Free PMC article. Review.
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous